SCHEMBL4452317

SCHEMBL4452317

CCCc1cc(-c2cccc(C(C)=O)c2)nc(C#N)n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CTSK P43235 20/20 1.00
CTSS P25774 17/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4453859 0.82 CTSK (1.00) CTSKCTSS
SCHEMBL4446022 0.82 CTSK (1.00) CTSKCTSS
SCHEMBL4442260 0.81 CTSK (1.00) CTSKCTSS
SCHEMBL4446363 0.81 CTSK (1.00) CTSKCTSS
SCHEMBL4446357 0.79 CTSK (1.00) CTSKCTSS
SCHEMBL4444428 0.79 CTSK (1.00) CTSKCTSS
SCHEMBL4442137 0.78 CTSK (0.66) CTSKCTSS
SCHEMBL4444344 0.78 CTSK (1.00) CTSKCTSS
SCHEMBL4445034 0.77 CTSK (1.00) CTSKCTSS
SCHEMBL5548112 0.76 CTSK (0.93) CTSKCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7589095-B2 4-phenyl-pyrimidine-2-carbonitrile derivatives N.V. ORGANON (NL) 2009-09-15 US disclosed
US-20080090813-A1 4-Phenyl-Pyrimidine-2-Carbonitrile Derivatives Cai, Jiaqiang 2008-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090813-A1 4-Phenyl-Pyrimidine-2-Carbonitrile Derivatives P2RY4, P2RX4, P2RY1 CTSK 1852/4885CTSS 2645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.